CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndTotal non-current assets (Million JPY)YoY (%)
Jun 30, 202594-24.52%
Jun 30, 2024124+578.42%
Jun 30, 202318-42.90%
Jun 30, 202232+1.09%
Jun 30, 202132+1.34%
Jun 30, 202031+0.22%
Jun 30, 201931-1.70%
Jun 30, 201832+61.33%
Jun 30, 201720-55.02%
Jun 30, 201644-2.05%
Jun 30, 201545-17.57%
Jun 30, 201454
AI Chat